Güleser SAYLAM, Ömer BAYIR, Mehmet Hakan KORKMAZ, Muhammed Erkam SENCAR, İlknur ÖZTÜRK ÜNSAL, Mehmet Furkan ÇIRAKOĞLU, Volkan YÜCEL

Relationship Between Parathormone and Inflammatory Markers on Complete Blood Count in Parathyroid Adenoma Patients

Objective: To investigate the effects of surgical treatment on blood parameters in patients with parathyroid adenoma. Methods: Patients with a diagnosis of parathyroid adenoma, who underwent surgery between November 2011 and April 2016, were investigated retrospectively. These patients were evaluated according to white blood cell, lymphocyte, neutrophil, and platelet counts, hematocrit, mean platelet volume (MPV), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and calcium and parathormone (PTH) levels before and after the surgery. Results: The study included 103 patients. The number of male patients was 22 (21.4%), and the number of female patients was 81 (78.6%). The age of the patients ranged between 7 and 87, and the mean age was 54.7 ± 14.3. Preoperative and postoperative changes in lymphocyte, platelet, hematocrit, MPV, calcium and PTH levels were found to be statistically significant in our study, but the changes in NLR and PLR were not. Conclusion: Hyperparathyroidism is a reason for chronic inflammation and may affect blood inflammation parameters. However, the correlation between NLR, PLR, and serum PTH levels was not statistically significant. This can be explained by the fact that surgery causes a significant change in the number of both platelets and lymphocytes. We found a positive correlation between lymphocyte, neutrophil, and platelet counts, hematocrit, MPV, and serum PTH levels.

PDF

___

1. Han CH, Fry CH, Sharma P, Han TS. A clinical perspective of parathyroid hormone related hypercalcaemia. Rev Endocr Metab Disord. 2020;21(1):77-88. [CrossRef]
2. Silverberg SJ, Bilezikian JP. The diagnosis and management of asymptomatic primary hyperparathyroidism. Nat Clin Pract Endocrinol Metab. 2006;2(9):494-503. [CrossRef]
3. Arpaci D, Kuzu F, Emre AU, et al. Elevated mean platelet volume in patients with primary hyperparathyroidism. Int J Clin Exp Med. 2016;9:6330-6335.
4. Christensen MHE, Fenne IS, Nordbø Y, et al. Novel inflammatory biomarkers in primary hyperparathyroidism. Eur J Endocrinol. 2015;173(1):9-17. [CrossRef]
5. Chertok-Shacham E, Ishay A, Lavi I, Luboshitzky R. Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism. Med Sci Monit. 2008;14(12):CR628-CR632.
6. Almqvist EG, Bondeson AG, Bondeson L, Svensson J. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Investig Suppl. 2011;71(2):139-144. [CrossRef]
7. Bollerslev J, Rosen T, Mollerup CL, et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab. 2009;94(7):2255-2261. [CrossRef]
8. Yang PS, Liu CL, Liu TP, et al. Parathyroidectomy decreases neutrophil- to-lymphocyte and platelet-to-lymphocyte ratios. J Surg Res. 2018;224:169-175. [CrossRef]
9. Christensen MHE, Pedersen EKR, Nordbø Y, et al. Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism. J Intern Med. 2012;272(6):583-591. [CrossRef]
10. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.
11. Butterworth RJ, Bath PMW. The relationship between mean platelet volume, stroke subtype and clinical outcome. Platelets. 1998;9(6):359- 364. [CrossRef]
12. Yaprak M, Turan MN, Dayanan R, et al. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol. 2016;48(8):1343-1348. [CrossRef]
13. Bath PMW, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7(2):157-161. [CrossRef]
14. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka- Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators Inflamm. 2019;2019:9213074. [CrossRef]
15. Irkorucu O. Mean platelet volume and solitary parathyroid adenoma. Int J Clin Exp Med. 2016;9:14536-14541.
16. Adhikary LP, Pokhrel A, Yadava SK, Khadka D, Thakur R. Relation between serum intact parathyroid hormone level and hematocrit in chronic kidney disease patients. Kathmandu Univ Med J (KUMJ). 2015;13(51):220-223. [CrossRef]
17. Meytes D, Bogin E, Ma A, Dukes PP, Massry SG. Effect of parathyroid hormone on erythropoiesis. J Clin Invest. 1981;67(5):1263-1269. [CrossRef]
18. Bhadada SK, Bhansali A, Ahluwalia J, et al. Anaemia and marrow fibrosis in patients with primary hyperparathyroidism before and after curative parathyroidectomy. Clin Endocrinol (Oxf). 2009;70(4):527-532. [CrossRef]
19. Waugh DJJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735-6741. [CrossRef]
20. De Larco JE, Wuertz BRK, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin- 8. Clin Cancer Res. 2004;10(15):4895-4900. [CrossRef]
21. Doherty CC, Labelle P, Collins JF, Brautbar N, Massry SG. Effect of parathyroid hormone on random migration of human polymorphonuclear leukocytes. Am J Nephrol. 1988;8(3):212-219. [CrossRef]
22. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol. 1991;11(2):102-111. [CrossRef]
23. Salant DJ, Glover AM, Anderson R, et al. Polymorphonuclear leucocyte function in chronic renal failure and after renal transplantation. Proc Eur Dial Transplant Assoc. 1976;12:370-379.
24. Khan F, Khan AJ, Papagaroufalis C, et al. Reversible defect of neutrophil chemotaxis and random migration in primary hyperparathyroidism. J Clin Endocrinol Metab. 1979;48(4):582-584. [CrossRef]
25. Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69(13):5383-5391. [CrossRef]
26. Ownby HE, Roi LD, Isenberg RR, Brennan MJ. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 1983;52(1):126-130. [CrossRef]
27. Lewin E, Ladefoged J, Brandi L, Olgaard K. Parathyroid hormone dependent T cell proliferation in uremic rats. Kidney Int. 1993;44(2):379-384. [CrossRef]
28. Klinger M, Alexiewicz JM, Linker-Israeli M, et al. Effect of parathyroid hormone on human T cell activation. Kidney Int. 1990;37(6):1543- 1551. [CrossRef]
29. Shasha SM, Kristal B, Steinberg O, Shkolnik T. Effect of parathyroidectomy on T cell functions in patients with primary hyperparathyroidism. Am J Nephrol. 1989;9(1):25-29. [CrossRef]
30. Alexiewicz JM, Klinger M, Pitts TO, et al. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure. J Am Soc Nephrol. 1990;1(3):236-244. [CrossRef]
31. Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2. [CrossRef]
32. Mallappa S, Sinha A, Gupta S, Chadwick SJD. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis. 2013;15(3):323-328. [CrossRef]
33. Liu CL, Lee JJ, Liu TP, et al. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol. 2013;107(5):493-497. [CrossRef]
34. Zeren S, Yaylak F, Ozbay I, Bayhan Z. Relationship between the neutrophil to lymphocyte ratio and parathyroid adenoma size in patients with primary hyperparathyroidism. Int Surg. 2015;100(7-8):1185-1189. [CrossRef]
35. Kucuk H, Tecer D, Goker B, et al. Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis. Adv Rheumatol. 2019;60(1):4. [CrossRef]